Evaxion A (EVAX) Shares Outstanding (2019 - 2026)
Evaxion A (EVAX) posted Shares Outstanding (Entity) of $8.3 million for Q1 2026, up 30.15% on a QoQ basis from $6.4 million in Q4 2025, and up 50.92% year-over-year from $5.5 million in Q1 2025.
Evaxion A (EVAX) Shares Outstanding (2019 - 2026) Analysis & Trends
Evaxion A's Shares Outstanding (Entity) history runs 8 years deep, the most recent figure standing at $8.3 million for Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 50.92% year-over-year to $8.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.3 million (up 50.92% YoY) and the FY2025 annual result came in at $6.4 million, up 19.46% from the prior year.
- Shares Outstanding (Entity) was $8.3 million for Q1 2026 at Evaxion A, up from $6.4 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $138.3 million in Q3 2023 and bottomed at $2.4 million in Q4 2022.
- A 5-year average of $45.4 million and a median of $10.8 million in 2023 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) sank 97.57% — and 2024, when it surged 96.24%.
- Evaxion A's Shares Outstanding (Entity) stood at $2.4 million in 2022, then gained by 15.64% to $2.7 million in 2023, then jumped by 96.24% to $5.4 million in 2024, then gained by 19.46% to $6.4 million in 2025, then soared by 30.15% to $8.3 million in 2026.
- Business Quant data shows EVAX's Shares Outstanding (Entity) at $8.3 million in Q1 2026, $6.4 million in Q4 2025, and $6.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 47.82 Bn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.44 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 62.06 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 198.10 Mn |
| 10 | Evaxion A | 1.23 Bn | 1.23 Bn | - | 417.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 417.01 Mn |
| Dec 31, 2025 | 320.41 Mn |
| Sep 30, 2025 | 318.04 Mn |
| Jun 30, 2025 | 315.83 Mn |
| Mar 31, 2025 | 276.31 Mn |
| Dec 31, 2024 | 53.64 Mn |
| Sep 30, 2024 | 276.28 Mn |
| Jun 30, 2024 | 53.79 Mn |
| Mar 31, 2024 | 233.19 Mn |
| Dec 31, 2023 | 27.34 Mn |
| Sep 30, 2023 | 1.38 Bn |
| Jun 30, 2023 | 132.19 Mn |
| Mar 31, 2023 | 1.29 Bn |
| Dec 31, 2022 | 23.64 Mn |
| Sep 30, 2022 | 1.19 Bn |
| Jun 30, 2022 | 1.17 Bn |
| Mar 31, 2022 | 1.16 Bn |
| Dec 31, 2021 | 974.66 Mn |
| Sep 30, 2021 | 959.93 Mn |
| Jun 30, 2021 | 959.93 Mn |